Correspondence on "Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative and Oncologic Outcomes" by Valentina Ghirardi et al

Ann Surg Oncol. 2024 Jul;31(7):4582-4583. doi: 10.1245/s10434-024-15399-2. Epub 2024 May 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemotherapy, Adjuvant
  • Cytoreduction Surgical Procedures*
  • Female
  • Humans
  • Hyperthermic Intraperitoneal Chemotherapy*
  • Neoadjuvant Therapy*
  • Neoplasm Staging*
  • Ovarian Neoplasms* / drug therapy
  • Ovarian Neoplasms* / pathology
  • Ovarian Neoplasms* / surgery
  • Ovarian Neoplasms* / therapy
  • Prognosis
  • Prospective Studies
  • Survival Rate